BioCentury | Sep 29, 2014
Finance

CureVac bet paying off

...responses against all five antigens contained in the vaccine: melanoma-associated antigen family C 1 ( MAGEC1...
BioCentury | Sep 22, 2014
Company News

CureVac, Boehringer Ingelheim deal

...codes for six antigens frequently expressed on NSCLC cells: melanoma-associated antigen family C 1 ( MAGEC1...
BioCentury | Sep 19, 2014
Company News

Boehringer licenses CureVac's CV9202

...vaccine codes for six antigens frequently expressed on NSCLC cells: melanoma-associated antigen family C 1 (MAGEC1...
BioCentury | Aug 26, 2010
Distillery Therapeutics

Indication: Cancer

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Melanoma Melanoma-associated antigen C1 (MAGEC1; CT7) A study...
Items per page:
1 - 4 of 4